Ocugen, Inc. 8-K

What Happened Ocugen, Inc. filed a Form 8-K on March 27, 2026 to disclose a presentation under Item 7.01 (Regulation FD). The presentation is furnished as Exhibit 99.1, will be posted on Ocugen’s website (www.ocugen.com), and may be used in presentations or discussions with investors, analysts, or other parties. The filing also includes the interactive Inline XBRL cover page (Exhibit 104).

Key Details

• Filing date: March 27, 2026; Item reported: 7.01 (Regulation FD Disclosure).
• Investor presentation furnished as Exhibit 99.1 and to be posted at www.ocugen.com.
• Interactive XBRL cover page included as Exhibit 104.
• The 8-K does not report earnings, executive changes, or other material events beyond the Regulation FD disclosure.

Why It Matters This filing makes Ocugen’s investor presentation publicly available and documents the company’s compliance with Regulation FD, which is intended to ensure information is shared broadly rather than selectively. Investors should review the posted presentation for any business, pipeline or strategic updates the company chose to disclose; because the 8-K does not include earnings or personnel changes, it does not itself change Ocugen’s financial statements or management status.